
Results
180
Companies which are potentially undervalued and in an acceptable financial position.
180 companies
High Tide
Market Cap: CA$261.0m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$2.97
7D
2.4%
1Y
-1.7%
United Therapeutics
Market Cap: US$21.9b
Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$516.31
7D
-1.4%
1Y
69.4%
Arcutis Biotherapeutics
Market Cap: US$3.2b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$25.94
7D
-8.7%
1Y
69.3%
Zhejiang Jiuzhou Pharmaceutical
Market Cap: CN¥13.0b
Operates as contract development and manufacturing organization (CDMO) company in China and internationally.
603456
CN¥15.73
7D
10.3%
1Y
-15.7%
CorMedix
Market Cap: US$592.3m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.55
7D
2.7%
1Y
-37.4%
Hypera
Market Cap: R$15.1b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.52
7D
0.4%
1Y
-14.1%
Kissei Pharmaceutical
Market Cap: JP¥159.8b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,875.00
7D
-8.6%
1Y
-12.9%
Innovent Biologics
Market Cap: HK$149.7b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$86.70
7D
-3.6%
1Y
-12.2%
Supernus Pharmaceuticals
Market Cap: US$2.7b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$46.00
7D
-3.6%
1Y
22.6%
Kuros Biosciences
Market Cap: CHF 887.8m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 22.50
7D
9.9%
1Y
-21.6%
UCB
Market Cap: €42.2b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€221.40
7D
-11.5%
1Y
18.5%
Yunnan Baiyao GroupLtd
Market Cap: CN¥93.3b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥51.70
7D
0.5%
1Y
-8.0%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩258,000.00
7D
8.6%
1Y
-21.1%
Prestige Consumer Healthcare
Market Cap: US$2.5b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$51.92
7D
0.4%
1Y
-29.9%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €196.2m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.34
7D
1.2%
1Y
2.0%
Bavarian Nordic
Market Cap: DKK 13.7b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 179.80
7D
0.8%
1Y
-24.7%
Diaceutics
Market Cap: UK£123.6m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.46
7D
15.4%
1Y
6.2%
Shionogi
Market Cap: JP¥2.5t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,773.00
7D
-4.5%
1Y
7.1%
Ardelyx
Market Cap: US$1.2b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$4.98
7D
-2.1%
1Y
-2.9%
Dong-E-E-Jiao
Market Cap: CN¥35.4b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥54.60
7D
5.0%
1Y
5.7%
Fennec Pharmaceuticals
Market Cap: US$333.1m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$9.59
7D
-3.5%
1Y
17.4%
Journey Medical
Market Cap: US$178.1m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.47
7D
2.5%
1Y
-10.3%
Amoy Diagnostics
Market Cap: CN¥6.8b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥17.72
7D
5.0%
1Y
-25.5%
Decibel Cannabis
Market Cap: CA$57.7m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.10
7D
-9.1%
1Y
17.6%
Dong-A ST
Market Cap: ₩344.6b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩36,950.00
7D
3.1%
1Y
-16.0%
Perrigo
Market Cap: US$1.5b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$10.68
7D
3.7%
1Y
-59.9%
Exagen
Market Cap: US$113.1m
Designs, develops, and commercializes various testing products under the AVISE brand in the United States.
XGN
US$4.68
7D
5.2%
1Y
-47.2%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.55
7D
-1.8%
1Y
10.4%
Dermapharm Holding
Market Cap: €2.0b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€41.00
7D
-1.8%
1Y
22.9%
China Resources Pharmaceutical Group
Market Cap: HK$30.6b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.86
7D
0.4%
1Y
-8.5%
United Laboratories International Holdings
Market Cap: HK$17.8b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$9.11
7D
1.3%
1Y
-38.6%
Daewoong Pharmaceutical
Market Cap: ₩1.3t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩123,600.00
7D
-1.8%
1Y
-11.7%
Pacira BioSciences
Market Cap: US$1.1b
Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.
PCRX
US$26.92
7D
0.4%
1Y
19.4%
Vanda Pharmaceuticals
Market Cap: US$314.5m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$5.23
7D
1.4%
1Y
24.2%
Viatris
Market Cap: US$20.5b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$17.63
7D
-1.3%
1Y
96.3%
Trulieve Cannabis
Market Cap: US$1.7b
Operates as a cannabis retailer in the United States.
TRLV
US$8.60
7D
3.2%
1Y
55.0%